Advertisement
HealthDay Reports: Brazil

FDA Approves First Rapid COVID-19 Test for Home Use

0

Simple nasal swab test requires prescription; people younger than 14 cannot perform the test on themselves

Fluvoxamine Linked to Reduction in Clinical Deterioration in COVID-19

0

Findings seen among adult outpatients with SARS-CoV-2 with oxygen saturation of 92 percent or greater

FDA Approves First Ebola Virus Treatment

Ebola Outbreak in Democratic Republic of the Congo Declared Over

0

Wednesday marks 42 days, or two incubation periods, since the last survivor tested negative for the virus

B 11/20 -- Add Kids to COVID Vaccine Trials: Pediatricians

AAP Urges Inclusion of Children in SARS-CoV-2 Vaccine Trials

0

AAP joins six other medical groups in letter requesting transparency and communication to improve confidence in a vaccine

Periodontal Pathogens Linked to Atherosclerosis in RA

0

Immunoreactivity to Aggregatibacter actinomycetemcomitans serotype b, Aa leukotoxin A linked to atherosclerosis

Automated Alarm IDs Inpatients at Risk for Sudden Decline

Sixty-Day Outcomes Examined for Hospitalized COVID-19 Patients

0

29.2 percent died during hospitalization or within 60 days of discharge; ongoing morbidity was common

Okada Test Article

Routine COVID-19 Testing Improves Safety of Elective Surgery

0

Benefits of nasal swab testing seen in high-transmission areas and before major surgery

HealthDay Reports: Most Americans

Major U.S. Medical Groups Urge Trump to Work With Biden on Fighting COVID-19

0

In letter from three medical associations, the president is urged 'to share critical data and information as soon as possible'

HealthDay Reports: Coronavirus Has Killed Thousands at US Nursing Homes

Nebulized Interferon Beta-1a Promising for COVID-19

0

Adults hospitalized for COVID-19 receiving SNG001 versus placebo more likely to show clinical improvement

Persistent Fatigue Prevalent After COVID-19 Infection

0

More than half of those recovered from acute phase of COVID-19 experience postviral fatigue, independent of COVID-19 severity